Publications
Total number of publications: 250
2024
-
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
-
Cell Tree Rings: the structure of somatic evolution as a human aging timer
GEROSCIENCE, year: 2024, volume: 2024, edition: Jan, DOI
-
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
Molecular Cancer, year: 2024, volume: 23, edition: 1, DOI
-
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
-
Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease
Blood Cancer Journal, year: 2024, volume: 14, edition: 1, DOI
-
Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia
Journal of Clinical Lipidology, year: 2024, volume: 18, edition: 4, DOI
-
Diagnostic efficacy and clinical utility of whole-exome sequencing in Czech pediatric patients with rare and undiagnosed diseases
SCIENTIFIC REPORTS, year: 2024, volume: 14, edition: 1, DOI
-
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits
CELLULAR ONCOLOGY, year: 2024, volume: 47, edition: 6, DOI
-
Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab-exposed relapsed/refractory multiple myeloma patients: A retrospective analysis
European Journal of Haematology, year: 2024, volume: 113, edition: 6, DOI
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
Leukemia, year: 2024, volume: 38, edition: 7, DOI